https://www.forbes.com/sites/amyfeldman/2020/05/28/biotech-rd-software-startup-benchling-started-by-mit-undergrads-scores-850-million-valuation-amid-coronavirus-pandemic/
Forbes
Biotech R&D Software Startup Benchling, Started By MIT Undergrads, Scores $850 Million Valuation Amid Coronavirus Pandemic
Forbes Under 30 alum Sajith Wickramasekara scores an $850 million valuation for his biotech R&D startup Benchling. Amid the coronavirus pandemic, the company is helping big biotech companies work on potential therapeutics and vaccines for Covid-19.
